TYR and melanoma: It is a DNA vaccine expressing human tyrosinase (therefore defined as xenogeneic vaccine) against canine malignant melanoma [94], and delivered via a Transdermal Device, developed in conjunction with Bioject Inc [95], which delivers the vaccine without the use of a needle.